Drugs / ICOVIR-5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01864759 | Jan 2013 → Dec 2016 | melanoma | Catalan Institute of Oncology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICOVIR-5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01864759 ↗ |
| Route | Intravenous | “single administration, endovenous” NCT01864759 ↗ |